3-Fluoro-3-methyl-azetidine hydrobromide, 98%, 100mg

6-Chloroimidazo[1,2-b]pyridazine, 97.0%, 5g

(8-Bromonaphthalen-1-yl)methanol, 95.0%, 250mg

3-OXA-1,8-DIAZASPIRO[4.5]DECAN-2-ONE, 95.0%, 1g

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)

Gluconic acid potassium salt, min. 99%, for synthesis, 500 g, plastic packaging.

(S)-3,3'-Bis([1,1'-biphenyl]-4-yl)-[1,1'-binaphthalene]-2,2'-diol, 5g

5-BROMO-8-IODOQUINOLINE, 95.0%, 5g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(3-(tert-butoxy)-3-oxopropyl)glycine, 95+%, 250mg

4H-Chromen-4-one, 95.0%, 25g

4-Fluoro-2-(trifluoromethyl)benzyl Bromide>97.0%(GC)1g

potassium 4-isopropyl-1,3-thiazole-2-carboxylate, 95.0%, 10g

1-Indanone-6-carboxylic acid, 95.0%, 1g